Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Transition Therapeutics Inc

+ Add to Watchlist

TTH:CN

8.5500 CAD 0.4500 5.00%

As of 11:35:02 ET on 02/26/2015.

Snapshot for Transition Therapeutics Inc (TTH)

Open: 8.2500 Day's Range: 8.2500 - 8.5600 Volume: 643
Previous Close: 9.0000 52wk Range: 4.8000 - 9.4700 1-Yr Rtn: +6.88%

Stock Chart for TTH

No chart data available.
  • TTH:CN 8.5500
  • 1D
  • 1M
  • 1Y
9.0000
Interactive TTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTH

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -1.5150
Est. EPS (CAD) (06/2015) -1.3200
Est. PEG Ratio -
Market Cap (M CAD) 328.26
Shares Outstanding (M) 38.39
30 Day Average Volume 1,586
Price/Book (mrq) 10.7684
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TTH

Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.

Tony F CruzChairman/CEONicole Rusaw GeorgeChief Financial Officer
Carl DamianiChief Operating OfficerAleksandra PastrakVP:Clinical Dev/Medical Ofcr
More Company Profile & Key Executives for TTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil